Selective telomerase inhibitor (IC50
values are 93, > 100000 and > 100000 nM for human telomerase, human RNA polymerase I and human RNA polymerase II + III respectively). Causes telomere shortening in exponentially growing NCI-H460 lung carcinoma cells and eventual growth arrest.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Telomerase inhibitors and 'T-oligo' as caner therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin et al.
Anticancer Drugs, 2008;19:329
A highly selective telomerase inhibitor limiting human cell proliferation.
Damm et al.
EMBO J., 2001;20:6958
Telomerase and its potential for therapeutic intervention.
Phatak and Burger
The citations listed below are publications that use Tocris products. Selected citations for BIBR 1532 include:
Showing Results 1 - 1 of 1